This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Advancing Cell Technology
Regenicin News
Regenicin, Inc. begins engineering runs on NovaDerm manufacturing.
NovaDerm
A cultured cell technology that uses the patient’s own skin cells to generate living, tissue-engineered skin for the treatment of severe burns.
Redefining Cultured Cell Technologies
100+ Years
of Collective Expertise
We are a biotechnology company specializing in the development
of regenerative cell therapies to restore the health of damaged tissues and organs.
Our Mission
Transforming Lives with Regenerative Cell Therapies
Founded in 2010, we are pioneering breakthrough treatments like our cultured skin substitute—a living, tissue-engineered solution that accelerates healing for catastrophic burns. Driven by a world-class team and powered by innovation, we’re shaping a new era in regenerative medicine.